Effect of suplatast tosilate for moderate to severe uncontrolled asthmatic children who treated by ICS and LTRA(SMAC sutudy)
Not Applicable
Recruiting
- Conditions
- Asthma
- Registration Number
- JPRN-UMIN000008418
- Lead Sponsor
- Study group of the treatment of childfood asthma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Not provided
Exclusion Criteria
1. Case which has anamnesis of hypersensitivity to spulatast tosilate. 2. Case which is using Symbicoat or Adair . 3. Case which newly uses systemic steroid from temporary registration date. 4. Case which receive newly hyposensitization or nonspecific immnotherapy from temporary registration date. 5. Case which has impaired liver function. 6. Case considered that there are complications, such as chronic bronchitis, pulmonary emphysema, and bronchiectasis, and it interferes with judgement of effect of a medicine . 7. In addition, case which has serious illness complications. 8. In addition, case which family doctor judged to be unsuitable as experimental object.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of chang of the asthma symptom score at the time of registration and the score at twelve week later.(The score made by the comittee of asthma severity judging standard of Japanese society of Allergology.
- Secondary Outcome Measures
Name Time Method